Please login to the form below

Not currently logged in
Email:
Password:

Study sheds light on grey matter

Changes in the levels of the neurotransmitter dopamine may explain brain grey matter reductions experienced by patients with fibromyalgia, a study has found

A new brain imaging study has shown that changes in the levels of the neurotransmitter dopamine may explain brain grey matter reductions experienced by patients with fibromyalgia.

Previous research found an association between fibromyalgia and reductions in grey matter, but the cause wasn't known, say the researchers.

In this new study, Dr Patrick B Wood, of Louisiana State University Health Sciences Center, Shreveport in the US and colleagues used MRI to compare the brains of 30 women with fibromyalgia and 20 healthy women of the same age. Significant reductions in grey matter were found in the fibromyalgia patients, confirming previous findings.

The new study also found that fibromyalgia patients showed a strong correlation of dopamine metabolism levels and grey matter density in areas of the brain where dopamine is known to control neurological activity.

This association between dopamine levels and grey matter density offers new information about a possible mechanism behind some of the brain abnormalities seen in fibromyalgia patients, researchers concluded.

The study is published in the Journal of Pain (June issue).

22nd June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics